Agios Pharmaceuticals
AGIO
AGIO
189 hedge funds and large institutions have $3.03B invested in Agios Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 69 increasing their positions, 61 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 36
25% less capital invested
Capital invested by funds: $4.06B → $3.03B (-$1.03B)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
189
Holding in Top 10
2
Calls
$28.6M
Puts
$22.9M
Top Buyers
| 1 | +$156M | |
| 2 | +$51.3M | |
| 3 | +$27.8M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$23.2M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$15.5M |
Top Sellers
| 1 | -$149M | |
| 2 | -$66.9M | |
| 3 | -$15.2M | |
| 4 |
JP Morgan Chase
New York
|
-$12M |
| 5 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
-$8.11M |